















Wesoughtto defermlnewhetherthe Isoelactrlcwindowis reallyelectrically
silentor whetheractivationoocursduringthis intervalbut onlypropagates
locally(Locally-PropagatedAclivity,LPA)In a smallregionbeforeit blocks
and is extinguished.Sequencesof epicardialactivationsweremappedbe-
fore and.afterattempteddefibrillation(RV-SVCCOIIS)withblphasicshocks
havingstrengthneardefibrillationthreshold(DFT)in5 pigs.Unipolarepicar-
dial eleorrograms~(t)] wereaoquiredfroma 504electrodesock(s 4 mm
Irttereleotrodespacing)pulledovertheventricles.in eachanimal,10shocks
at DFTweredeliveredafter 10 s of VF induofion.Localactivationswere
definedby dV/dts –0.5 V/sand weredetectablestarting20 msafterthe
shock.Resrdts:LPAswereobservedfollowingall su&essful(S)andfailed
(F) shocks.LPAsoccurredin 3 + 3 regionsand eachregionoentained7
+ 6 recordingelectrodes.Whilethe timeafterthe shockwasnotdifferent
for the appearanceof EAs(64 + 10’ms for S and 62 + 9 msfor F) the
timeof appearancewasdifferent(P < 0.001)for S LPAs(41+ 16ms)than


























fibrillationin 7 out of 10 patients.Whenatrfaldefibrillationwasperformed
givingtheshocks50msecafterthebeginningof therightventricularelaotro-
grsmprosrrhyfhmiaweeseenin 1patientoutof 10.Noneofthepatientshad
shock-inducedproarrhythmiausinga delayof 70 msec.Inconclusion,atrfal









efficacyis due to its betablockingactivityor its olassthree antiarrhythmic
effect.Weanalyzedin a prospectiverandomizedstudytha clinicaleflioaoy
of SOTin comparisonto the betablwkermetoprckd(MET)in 112petients
(P)withan implantedcerdiovefierdefibrillator.In all P SOTdid not prevent
inductionofVTVFduringalectrophysiologictesting.Thegroupsdidnotdiffer
in respectto age,underlyingcardiacdisease(COp = 0.53),leftventricular
function(EF,p = 0.72)orcllnicalarrhythmia(VTIVF,p = 0.41).
Age CD EF VTIVF
SOtalOl(n =55) 61 + 734 CAD (67%)10 DCM (18%) 37+ 1429 (49%)/26 (51%)
M@oprolol(n=57) 63+8 43 CAD (77%) 8 DCM (11%) 38+ 1433 (58%)/24 (42%)
Meanfoiiow-upin PtreatadwithSOTwas691+ 537days,in Preceiving
METthefollow-upwas742+ S05days(p= 0.42).51%of the Ptreatedwith
SOThada VTNFepiscde(follow-upof 208+ 328days)oomparedto 47%
of PtreatedwithMET(follow-up238+ 232days,p = 0.33).1 P in the SOT
grouphada torsadesdepointes.
Cono/usiorr:Thepurebeta-blockerMetoprololisaseffectiveasSotalolin










mayreducepatientacceptanceof Impiarrtabladevicesfor attial fibrillation.
Weassessedwhethershocksof differentenergylevelsor deliveredat night
duringsleepcouidreducethe perceptionof pain. In 29 patientswith im-
planfebiedefibrillator,shocksof 1 end5 Joules(group1-10 patients),and
of 5 and 10Joulas(group2-19 patients)wererandomlydeliveredwiththe
patientsawake.In group2, the 10Joulesshockwasdeliveredagaindur-
ingthe nightwhilepatientswereaaleep.Patientswereaskedto gradethe
intensityof discomfortusingtwodifferentscales(fromoneto ten, andfmm
absento exfremeiysevere).Patientswerealsoaskedif theytoleratedbetter
theasieapvs.theawakeshmk. Nodifferencein discomfotiwasreportedin
group 1 between 1 and 5 Joules (aCore 1 Joule &3 + 1.9 ve 5 Joules &O +
2.1,p = NS)andingroup2 between5 and10Jouiesshocks(score5 Joules.
6.1 + 2.2 vs 10Joules5.6 + 2.0, p = NS).Usuallythe secondshockwas
perceivedasstrongerregardlessof theenergyused(p < 0.0005).In 14pe-
tientsshockduringsleepwasbettertolerated(p c 0.0001),3 patientsdidnot
reportanydifference,andtheremainingtwopatientsfeltmoreuncomfortable
dueto theirsubsequentinabilityto fallasleepagain.In conclusion:(1)atrial
defibrillationduringsleepmayreducethediscomfortassociatedwithenergy












.sotalol(SOT)is the mostimportantantiarrhyfhmicdrugfor thetreatmentof
sustainedventriculartachyarrhyfhmias.Howeverit is unknownwhetherits
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